The purpose of this study is to investigate the effect on repeat doses of GSK2190915 in
asthmatic patients with a high percentage of neutrophils in their sputum. GSK2190915 will be
given as an add on to current therapy, and its effects on the percentage of sputum
neutrophils in the patients will be assessed.